Anzeige
Mehr »
Login
Mittwoch, 15.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Das 13-Millionen-Unternehmen mit einer Monster-Entdeckung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
438 Leser
Artikel bewerten:
(2)

Marula Mining Plc - Confirmation of Key Board Appointments

Finanznachrichten News

Marula Mining Plc - Confirmation of Key Board Appointments

PR Newswire

LONDON, United Kingdom, August 16

Marula Mining PLC

("Marula' or the "Company")

16 August 2023

Confirmation of Key Board Appointments

Marula Mining (AQSE: MARU), an African focused mining and development company, is pleased to announce that, further to the announcement on 24 July 2023, Ms Hannah Wang'ombe and Mr Munyaradzi Murape have today been appointed as Independent Non-Executive Directors of the Company with immediate effect following completion of standard regulatory and due diligence reviews by the Company's advisers.

These appointments are in addition to the appointment of Ms Angeline Greenwood as Independent Non-Executive Director and the re-appointment of Mr Richard Lloyd as Chairman.

These appointments are important as the Company looks to continue to strengthen its Board with the appointment of experienced independent directors to assist and guide the executive management team in delivering on its strategy.

Ms Hannah Wang'Ombe - Independent Non-Executive Director

Ms Wang'Ombe is currently the CEO of the Association of Women in Extractives Kenya, an organisation that provides women with opportunities for equitable professional and economic development within the Kenya mining sector. Hannah has over 10 years' experience in stakeholder engagement, relationship building, crisis management, and public policy processes at the Kenya Institute for Public Policy Research and Analysis, where she worked as a Researcher and Head of Strategy and Planning.

Ms Wang'Ombe will also assume the role of Chair of the Environment and Social Responsibility Committee and be a member of the Remuneration and Nomination Committee.

Save as set out below, no further information regarding Ms Hannah Kevin Watheri Wang'Ombe is required to be disclosed pursuant to Rule 4.9 of the AQSE Growth Market Access Rulebook.

Ms Hannah Kevin Watheri Wang'Ombe (aged 41) has held the following current and former directorships within the past five years:

Current Directorships

Former Directorships in the past five years

Laurel Sterling Limited

None

Ms Wang'Ombe holds no ordinary shares or warrants or options over ordinary shares in the Company.

There is no further information to be disclosed pursuant to Rule 4.9 of the AQSE Growth Market Access Rulebook.

Mr Munyaradzi Murape - Independent Non-Executive Director

Munyaradzi Murape is the CEO of Redstone Partners Limited, a UK-headquartered financial markets development company focused on the Southern African region. He began his career working in investment banking in Zimbabwe, for a range of banks including HSBC (Private) Securities Limited and CBZ Bank Limited. Munyaradzi has over 20 years' experience as an investment banker, corporate leader, public and private sector investor. In 2015, he earned the award of the Archbishop Tutu Fellowship at Oxford University.

Mr Murape will also assume the role of member of the Audit Committee and member of the Risk Committee.

Save as set out below, no further information regarding Mr Munyaradzi Wenceslaus Murape is required to be disclosed pursuant to Rule 4.9 of the AQSE Growth Market Access Rulebook.

Mr Munyaradzi Wenceslaus Murape (aged 46) has held the following current and former directorships within the past five years:

Current Directorships

Former Directorships in the past five years

BLM Global Partners RSA (Pty) Ltd

Atria Capital (Pty) Ltd

Mra Tau Group (Pty) Ltd

Growth Cycle Ventures (Pty) Ltd

Orwell Development Partners Ltd

Hortiflora (Pty) Ltd

Redstone Partners Limited

LTM Investments (Pty) Ltd

Redstone Zambia Limited

MTZ Mining (Pty) Ltd

Rendi Petroleum (Pty) Ltd

National Student Housing Development Partnership (Pty) Ltd

Oyster Shell Property Fund (Pty) Ltd

Unearth Energy (Pty) Ltd

Unearth International (Pty) Ltd

Weben Global Partners (Pty) Ltd

Mr Murape holds no ordinary shares or warrants or options over ordinary shares in the Company.

There is no further information to be disclosed pursuant to Rule 4.9 of the AQSE Growth Market Access Rulebook.

Jason Brewer, Marula Mining PLC CEO, said:

"We are thrilled to officially welcome Ms. Hannah Wang'Ombe and Mr. Munyaradzi Murape to the Board of Directors as Independent Non-Executive Directors following completion of the necessary regulatory and due diligence reviews.

"This implemented strengthening of the Board will put the Company in an excellent position as we continue ahead with our various new mine developments, dual listings in South Africa and Kenya, and with the planned new primary listing on AIM."

The Directors of Marula are responsible for the contents of this announcement. This announcement contains inside information for the purposes of UK Market Abuse Regulation.

About Marula Mining

Marula Mining (AQSE: MARU) is an African focused battery metals investment and exploration company and has interests in several high value mine projects in Africa; Blesberg Lithium and Tantalum Mine in South Africa, Nkombwa Hill Project in Zambia and Kinusi Copper mine, Bagamoyo Graphite Project and Nyorinyori Graphite Project in Tanzania. As we advance operations at these battery metals focused projects, Marula will continue to build and expand its interests in other high-quality projects in Africa.

Marula's strategy is to identify and invest in advanced and high-value mining projects throughout East, Central and Southern Africa that the Directors believe would deliver returns for its shareholders. The Board and management team aims to establish Marula as a socially and environmentally responsible, sustainable, and profitable producer of critical metals and commodities that are of increasingly strategic importance to modern technologies and the global economy.

Marula's shares are traded on the AQUIS Stock Exchange (AQSE), Marula is exploring opportunities to admit its shares to trading on AIM, the market operated by the London Stock Exchange Group plc, Kenya's Nairobi Securities Exchange and South Africa's Johannesburg Stock Exchange.

For enquiries contact:

Marula Mining PLC

Jason Brewer,

Chief Executive Officer

Faith Kinyanjui Mumbi

Investor Relations

Email: jason@marulamining.com

Email: info@marulamining.com

AQSE Corporate Adviser

Cairn Financial Advisers LLP,

Liam Murray / Ludovico Lazzaretti

+44 (0)20 7213 0880

Broker

Peterhouse Capital Limited,

Charles Goodfellow / Duncan Vasey

+44 (0)20 7469 0930

Financial PR and IR

BlytheRay

Tim Blythe / Megan Ray / Said Izagaren

+44 (0)20 7138 3204

Caution

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identi?ed by their use of terms and phrases such as 'believe', 'could', "should" 'envisage', 'estimate', 'intend', 'may', 'plan', 'potentially', "expect", 'will' or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements re?ect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.




© 2023 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.